Upneeq is the FIRST AND ONLY, FDA-approved, non-invasive treatment to improve low-lying lids by contracting the Mueller’s Muscle. Upneeq is used to treat acquired blepharoptosis in adults.
- First In-Class Treatment
- Active Ingredient Oxymetazoline Hydrochloride. 1%
- Delivers rapid, visible lift to the upper eyelid with once-daily use
- 1mm-3mm average lift of upper eyelid
- Achieved significant visual field improvement
- Some patients may start to observe efficiency 5-15 minutes post-dose, Lasting effect up to 8 hours post-dose
- 0 Contraindications